Daclatasvir Dihydrochloride and Fiasp FlexTouch
Determining the interaction of Daclatasvir Dihydrochloride and Fiasp FlexTouch and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Fiasp, Fiasp Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Fiasp Injection
- Daclatasvir Dihydrochloride-Fiber Lax
- Daclatasvir Dihydrochloride-Fiber Laxative
- Daclatasvir Dihydrochloride-FiberCon
- Daclatasvir Dihydrochloride-FiberGen
- Daclatasvir Dihydrochloride-Fibertab
- Fiasp FlexTouch-Daclizumab
- Fiasp FlexTouch-Daclizumab Subcutaneous
- Fiasp FlexTouch-Dacogen
- Fiasp FlexTouch-Dacomitinib
- Fiasp FlexTouch-Dactinomycin
- Fiasp FlexTouch-Dactinomycin Injection